Chugai Pharma | 4519 - Nettoeinkommen

Aktienkurs
8,845.00
Täglich Wechseln
-81.00 -0.91%
Monatlich
4.53%
Jährlich
6.90%
Q2 Prognose
8,027.56




Nettoeinkommen Veränderung Datum
Astellas Pharma JPY 100.38B 21.17B 2025-12
Chugai Pharma JPY 115.42B 12.99B 2026-03
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Eisai JPY 17.18B 7.02B 2025-12
Kyowa Hakko Kirin JPY 34.44B 18.16B 2025-12
M3 JPY 18.94B 8.07B 2025-12
Otsuka Holdings JPY 65.49B 58.64B 2025-12
Shionogi JPY 74.68B 30.5B 2025-12
Sumitomo Dainippon JPY 87.65B 76.45B 2025-09
Takeda JPY 103.64B 115.44B 2025-12
Terumo JPY 32.65B 2.4B 2025-12